Products for Research Use Only
RegisterLogin

Stamulumab

CAT: 0804-HY-P99588-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99588-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Stamulumab (MYO-029) is a recombinant human IgG1λ antibody that binds to myostatin and neutralizes its activity by preventing binding to its endogenous high-affinity receptor ActRIIB. Stamulumab leads to muscle fiber hypertrophy and not hyperplasia in SCID mice. Stamulumab has the potential for Becker muscular dystrophy (BMD), facioscapulohumeral dystrophy (FSHD), and limb-girdle muscular dystrophy (LGMD) research[1][2].
CAS Number
705287-60-1
Product Name Alternative
MYO-029
UNSPSC
12352203
Target
TGF-β Receptor
Type
Inhibitory Antibodies
Related Pathways
TGF-beta/Smad
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/stamulumab.html
Purity
95.07
Solubility
H2O
Smiles
[Stamulumab]
Molecular Weight
(142.56 kDa)
References & Citations
[1]P Singh, et al. Translational Pharmacokinetic/Pharmacodynamic Analysis of MYO-029 Antibody for Muscular Dystrophy. Clin Transl Sci. 2016 Dec;9 (6) :302-310.|[2]Kathryn R Wagner, et al. A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy. Ann Neurol. 2008 May;63 (5) :561-71.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2

Alternative Products

CatalogName
BA9171-5Stamulumab
WA3571Research Grade Stamulumab
E55B0548Stamulumab (Reference antibody)
592212Stamulumab (MSTN, GDF-8)
GTR18780753-01(Stamulumab) Biosimilar Reference Antibody
GTR18697627-01Stamulumab Human Monoclonal Antibody
ICH5883-20mgStamulumab Biosimilar - Research Grade
RA0512-01Stamulumab (Biosimilar Reference Antibody) (MSTN)
A135164Stamulumab Biosimilar (Monoclonal, IgG1-nd)
YR1127-01Anti-Human MSTN Recombinant Antibody (Stamulumab)

Popular Products